Search research articles
Contact Us
Filters
Showing results (11-20 of 20) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 20 results.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
October 10, 2015
CRISPR-mediated Genome Editing Restores Dystrophin Expression and Function in mdx Mice
Li Xu, Ki Ho Park, Lixia Zhao, et al.
Nature Communications
|
June 18, 2021
Efficient precise in vivo base editing in adult dystrophic mice
Li Xu, Chen Zhang, Haiwen Li, et al.
Skeletal Muscle
|
December 23, 2015
Genetic disruption of Ano5 in mice does not recapitulate human ANO5-deficient muscular dystrophy
Jing Xu, Mona El Refaey, Li Xu, et al.
Circulation Research
|
August 10, 2017
In Vivo Genome Editing Restores Dystrophin Expression and Cardiac Function in Dystrophic Mice
Mona El Refaey, Li Xu, Yandi Gao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 19, 2013
Efficacy of BET bromodomain inhibition in Kras-mutant non-small cell lung cancer
Takeshi Shimamura, Zhao Chen, Margaret Soucheray, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
March 22, 2025
DHODH inhibition alters T cell metabolism limiting acute graft-versus-host disease while retaining graft-versus-leukemia response
Rathan Kumar, Kara M Braunreiter, Lotus Neidemire-Colley, et al.
Frontiers in Oncology
|
November 1, 2021
Inhibition of Bromodomain and Extra Terminal (BET) Domain Activity Modulates the IL-23R/IL-17 Axis and Suppresses Acute Graft-<i>Versus</i>-Host Disease
Katiri J Snyder, Hannah K Choe, Yandi Gao, et al.
Blood Advances
|
January 5, 2024
CRISPR/Cas9 deletion of MIR155HG in human T cells reduces incidence and severity of acute GVHD in a xenogeneic model
Lotus Neidemire-Colley, Shrijan Khanal, Kara M Braunreiter, et al.
JCI Insight
|
March 20, 2020
PRMT5 regulates T cell interferon response and is a target for acute graft-versus-host disease
Katiri J Snyder, Nina C Zitzer, Yandi Gao, et al.
Cancer Research
|
July 6, 2019
CXCR7 Reactivates ERK Signaling to Promote Resistance to EGFR Kinase Inhibitors in NSCLC
Jeffrey H Becker, Yandi Gao, Margaret Soucheray, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 20) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 20 results.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
October 10, 2015
CRISPR-mediated Genome Editing Restores Dystrophin Expression and Function in mdx Mice
Li Xu, Ki Ho Park, Lixia Zhao, et al.
Nature Communications
|
June 18, 2021
Efficient precise in vivo base editing in adult dystrophic mice
Li Xu, Chen Zhang, Haiwen Li, et al.
Skeletal Muscle
|
December 23, 2015
Genetic disruption of Ano5 in mice does not recapitulate human ANO5-deficient muscular dystrophy
Jing Xu, Mona El Refaey, Li Xu, et al.
Circulation Research
|
August 10, 2017
In Vivo Genome Editing Restores Dystrophin Expression and Cardiac Function in Dystrophic Mice
Mona El Refaey, Li Xu, Yandi Gao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 19, 2013
Efficacy of BET bromodomain inhibition in Kras-mutant non-small cell lung cancer
Takeshi Shimamura, Zhao Chen, Margaret Soucheray, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
March 22, 2025
DHODH inhibition alters T cell metabolism limiting acute graft-versus-host disease while retaining graft-versus-leukemia response
Rathan Kumar, Kara M Braunreiter, Lotus Neidemire-Colley, et al.
Frontiers in Oncology
|
November 1, 2021
Inhibition of Bromodomain and Extra Terminal (BET) Domain Activity Modulates the IL-23R/IL-17 Axis and Suppresses Acute Graft-<i>Versus</i>-Host Disease
Katiri J Snyder, Hannah K Choe, Yandi Gao, et al.
Blood Advances
|
January 5, 2024
CRISPR/Cas9 deletion of MIR155HG in human T cells reduces incidence and severity of acute GVHD in a xenogeneic model
Lotus Neidemire-Colley, Shrijan Khanal, Kara M Braunreiter, et al.
JCI Insight
|
March 20, 2020
PRMT5 regulates T cell interferon response and is a target for acute graft-versus-host disease
Katiri J Snyder, Nina C Zitzer, Yandi Gao, et al.
Cancer Research
|
July 6, 2019
CXCR7 Reactivates ERK Signaling to Promote Resistance to EGFR Kinase Inhibitors in NSCLC
Jeffrey H Becker, Yandi Gao, Margaret Soucheray, et al.
Page
of 2